Figure 2.
Ultrasound image showing NX-1207 injection (arrow on left) in a subject with benign prostatic hyperplasia. (Nymox Pharmaceutical Corporation, Hasbrouck Heights, NJ, USA).
Ultrasound image showing NX-1207 injection (arrow on left) in a subject with benign prostatic hyperplasia. (Nymox Pharmaceutical Corporation, Hasbrouck Heights, NJ, USA).